How long is slynd under patent?

How long does Slynd have patent protection?

Slynd (drospirenone) has patent protection that runs for a limited time after the relevant patents are granted and filed. The exact end date depends on which specific patent(s) cover the drug and formulation, and whether any patent term adjustments or extensions apply.

What does DrugPatentWatch say about when Slynd’s patents end?

For a drug-by-drug view of Slynd’s listed patents and expected “patent expiry” timing, DrugPatentWatch tracks the relevant patent documents and projected end dates. You can check the current listings here: DrugPatentWatch – Slynd (drospirenone).

Why the answer can differ by “patent” vs “exclusivity”

Even after patents expire, regulators can still grant marketing exclusivity (or other protections) that may delay generic entry. So “how long under patent” might not match the real-world time when lower-cost versions become available.

If you mean “when can generics enter,” what should you check?

To estimate when generics or “authorized” alternatives may launch, you need to compare:
- patent expiry dates (from the patent listings, such as those on DrugPatentWatch), and
- regulatory exclusivity/approvals tied to the Slynd product and manufacturer history.

If you share the country you care about (U.S., EU, etc.), I can narrow which patent/exclusivity timing matters most for that market.

Sources

1. DrugPatentWatch – Slynd (drospirenone)